Benzinga | Nov 15, 2021 11:13AM EST

Bellerophon Therapeutics Q3 EPS $(0.49) Up From $(0.84) YoY

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.49) per share. This is a 41.67 percent increase over losses of $(0.84) per share from the same period last year.